• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION SD ALARIS SYSTEM; PUMP, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION SD ALARIS SYSTEM; PUMP, INFUSION Back to Search Results
Model Number 8100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Extravasation (1842)
Event Date 02/03/2023
Event Type  Injury  
Manufacturer Narrative
A follow up report will be submitted once the failure investigation has been completed.Per 803.52(f)(11)(iii), the information provided represents all of the known information at this time.The complainant or reporter was unable or unwilling to provide any further patient, product, or procedural details to the manufacturer.
 
Event Description
It was reported an "extravasation" to the right antecubital fossa (acf) following the administration of potassium "premix" and normal saline.It was reported that the arm became "swollen" and that there was no alarm from the pump "to alert occlusion/pressure." it was reported that the clinician then discontinued the peripheral intravenous catheter and dressing was applied."tubigrip" (bandage) was reportedly applied to the swollen arm with cold pack and the extremity was raised using "gallow sling." later on, the tubigrip was reportedly removed and "crepe support bandage" was applied while keeping the gallow sling.It was reported that the neurovascular status was "intact." it was reported a "temporary" harm and "minor treatment" was required.Please note that alaris system is neither designed nor intended to detect infiltrations / extravasation and does not alarm under infiltration / extravasation conditions.Although the pump module has downstream occlusion detection, occlusion alarms do not detect or prevent infiltration.
 
Event Description
It was reported an "extravasation" to the right antecubital fossa (acf) following the administration of potassium "premix" and normal saline.It was reported that the arm became "swollen" and that there was no alarm from the pump "to alert occlusion/pressure." it was reported that the clinician then discontinued the peripheral intravenous catheter and dressing was applied."tubigrip" (bandage) was reportedly applied to the swollen arm with cold pack and the extremity was raised using "gallow sling." later on, the tubigrip was reportedly removed and "crepe support bandage" was applied while keeping the gallow sling.It was reported that the neurovascular status was "intact." it was reported a "temporary" harm and "minor treatment" was required.Please note that alaris system is neither designed nor intended to detect infiltrations / extravasation and does not alarm under infiltration / extravasation conditions.Although the pump module has downstream occlusion detection, occlusion alarms do not detect or prevent infiltration.
 
Manufacturer Narrative
Omit: b21 - type of investigation not yet determined, c21 - results pending completion of investigation, d16 - conclusion not yet available, a device history record review is performed on each device reported in a mdr reportable event along with other methods of investigation as coded in section h6 of this mdr report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS SYSTEM
Type of Device
PUMP, INFUSION
Manufacturer (Section D)
CAREFUSION SD
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
brett wilko
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key16679590
MDR Text Key312672556
Report Number2016493-2023-140821
Device Sequence Number1
Product Code FRN
UDI-Device Identifier10885403810015
UDI-Public(01)10885403810015
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K133532
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
Report Date 04/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number8100
Device Catalogue Number8100 ALARIS LVP MODULE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/30/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/13/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/06/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
8015; 8100
Patient Outcome(s) Required Intervention;
-
-